“Enzyme strategies are very promising but they have been slow to develop because of the complexities around isolating what those enzymes were, establish what bacteria were producing them and trying then to select for increased production of those particular enzymes,” ​said Dr Todd Applegate, Poultry Science Department Head and Professor at the University of Georgia, addressing a webinar audience via the Phibro Academy platform.

However, he said that new technologies are emerging to accelerate this lengthy selection process.

“It is really coming from next generation sequencing looking at metagenomics and then genetically engineering and inserting the enzymes identified from those molecular processes into another microbe for a production vector.”

‘New technologies and approaches to deal with mycotoxins’

In his presentation on ‘New technologies and approaches to deal with mycotoxins’​, Applegate said that despite these complexities there were a lot of advantages to deploying enzymes for controlling mycotoxins at a feed level.

“The positives of an enzyme strategy are that it is highly specific and effective because it is rapid and irreversible, preserves other dietary nutrients (in contrast to binders), and is typically safe for animals and humans,” ​he noted.

However, the ‘cons’ of enzymes are that formulators need to think about their stability and how they will work in different matrices: “Are they stable enough to withstand the pelleting process and reach the gastro-intestine intact to have an impact on mycotoxins? Are the conditions right for the enzyme to work? As we think about enzymes, it’s important to consider the matrix within which they are going to have to work; consider factors like pH specificity, access to substrates, the water-to-solid relationship and passage rate through the digestive tract,” ​Dr Applegate advised.